InvestorsObserver
×
News Home

Should You Sell Avenue Therapeutics Inc (ATXI) Stock Friday?

Friday, May 07, 2021 10:46 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Sell Avenue Therapeutics Inc (ATXI) Stock Friday?

Avenue Therapeutics Inc (ATXI) stock is down -55.17% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ATXI stock a score of 34 out of a possible 100.

That rank is mainly influenced by a long-term technical score of 2. ATXI's rank also includes a short-term technical score of 3. The fundamental score for ATXI is 98. In addition to the average rating from Wall Street analysts, ATXI stock has a mean target price of 9. This means analysts expect the stock to gain 105.48% over the next 12 months.

Overall Score - 34
ATXI has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on ATXI!

What's Happening with ATXI Stock Today

Avenue Therapeutics Inc (ATXI) stock is higher by 3.55% while the S&P 500 is higher by 0.75% as of 10:43 AM on Friday, May 7. ATXI is higher by $0.15 from the previous closing price of $4.23 on volume of 69,010 shares. Over the past year the S&P 500 is higher by 46.92% while ATXI is down -55.17%. ATXI lost -$0.31 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Avenue Therapeutics Inc (ATXI) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App